Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone crossover trial for arterial stiffness in stable kidney transplant recipients on cyclosporine
2019-004243-74Phase 3Active
- Sponsor
- CHRU Nancy
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of eplerenone in arteriosclerosis (2 arms), sponsored by CHRU Nancy. Primary endpoint: Change in pulse wave velocity. Started Mar 2020; status: active.
02
Drugs
eplerenone
03
Conditions
arteriosclerosis
Beyond the preview
Go deeper on 2019-004243-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004243-74.